Scimago Lab
powered by Scopus
call: +1.631.470.9640
Mon-Fri 10 am - 2 pm EST


Medical Science Monitor Basic Research


eISSN: 1643-3750

Get your full text copy in PDF

18 F-Fluorodeoxyglucose triple-headed coincidence detection imaging in oncology: preliminary results and comparison with dedicated PET.

Stefaan Vandenberghe, Bieke Vandenbossche, Christophe Van de Wiele, Frederic De Winter, Damien Huglo, Rudi Dierckx

Med Sci Monit 2002; 8(6): MT89-94

ID: 420802

BACKGROUND: Dual head coincidence (DHC) imaging has been proposed as avaluable and cheaper alternative to oncological PET. The increased sensitivity of the recently-developedtriple-headed gamma camera (THC) optimized for coincidence detection has not been either validated orcompared to the sensitivity of a dedicated PET system in a clinical study.Material/Methods: Differencesin contrast-to-noise-ratio (CNR) between dedicated FDG PET, DHC and THC imaging were assessed using ahot sphere phantom. Twenty-two oncological patients were prospectively studied with consecutive wholebody FDG PET and FDG THC imaging. The images were visually read by 2 experienced nuclear medicine specialists.The diagnostic sensitivity of FDG THC imaging was assessed using FDG PET as the imaging gold standard.Lesion size was determined using computed tomography or magnetic resonance imaging.RESULTS: The meangain in CNR for THC as compared to DHC imaging was 35% (10-56%). Of 63 lesions, 58 (92%) on FDG PET werealso detected with THC imaging. Considering only lesions smaller than 15 mm, the relative sensitivitywas 86% (24/29). All lesions above 15 mm (n=34) were detected using THC imaging.CONCLUSIONS: The firstclinical results for THC imaging are promising. The overall relative sensitivity in this limited serieswas 92%. Only a few lesions smaller than 15 mm were missed.

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree